thrombosisjournal.com Report : Visit Site

Technical data of the thrombosisjournal.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host thrombosisjournal.com. Currently, hosted in United States and its service provider is Tiggee LLC .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Oscar Platform 201802052158-170 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

skip to content advertisement menu explore journals get published about bmc login my account search search all bmc articles search thrombosis journal menu home about articles submission guidelines search submit a manuscript featured article: noacs replace vka as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in the netherlands in 2012, around 400.000 patients in the netherlands were treated with vitamin k antagonists (vka) for thromboembolic diseases. since 2011, non-vka oral anticoagulants (noacs) are available. noacs do not require frequent inr monitoring which benefits patients, but also imposes a risk of reduced therapy adherence. the objective of this study is to describe uptake and patient adherence of noacs in the netherlands until october 2016. read the article world thrombosis day: preventing thrombosis and promoting high quality of life october 13th is world thrombosis day, a global movement that aims to focus attention on thrombosis, an often overlooked and misunderstood condition. to mark the occasion we invited tetsumei urano, an associate editor for thrombosis journal to tells us about the conditions that the day focuses on. read blog post here articles recent most accessed content type: review | 19 june 2018 activated protein c plays no major roles in the inhibition of coagulation or increased fibrinolysis in acute coagulopathy of trauma-shock: a systematic review authors: satoshi gando, toshihiko mayumi and tomohiko ukai content type: research | 5 june 2018 association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis authors: richard g. jung, pouya motazedian, f. daniel ramirez, trevor simard, pietro di santo, sarah visintini, mohammad ali faraz, alisha labinaz, young jung and benjamin hibbert content type: letter to the editor | 15 may 2018 thrombin generation in low plasma volumes authors: saartje bloemen, hilde kelchtermans and h. coenraad hemker content type: research | 1 may 2018 design and rationale of the non-interventional, edoxaban treatment in routine clinical practice in patients with venous thromboembolism in europe (etna-vte-europe) study authors: alexander t. cohen, cihan ay, philippe hainaut, hervé décousus, ulrich hoffmann, sean gaine, michiel coppens, pedro marques da silva, david jiménez, beatrice amann-vesti, bernd brüggenjürgen, pierre levy, julio lopez bastida, eric vicaut, petra laeis, eva-maria fronk… the correction to this article has been published in thrombosis journal 2018 16 :18 content type: research | 18 april 2018 noacs replace vka as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in the netherlands authors: j. m. van den heuvel, a. m. hövels, h. r. büller, a. k. mantel-teeuwisse, a. de boer and a. h. maitland-van der zee most recent articles rss view all articles content type: review | 3 july 2013 laboratory assessment of rivaroxaban: a review authors: meyer michel samama, geneviève contant, theodore e spiro, elisabeth perzborn, lena le flem, céline guinet, yves gourmelin, gabriele rohde and jean-luc martinoli content type: review | 31 december 2013 practical management of patients on apixaban: a consensus guide authors: christopher ward, greg conner, geoffrey donnan, alexander gallus and simon mcrae content type: original clinical investigation | 20 september 2013 oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the einstein-dvt and pe randomized studies authors: martin h prins, anthonie wa lensing, rupert bauersachs, bonno van bellen, henri bounameaux, timothy a brighton, alexander t cohen, bruce l davidson, hervé decousus, gary e raskob, scott d berkowitz and philip s wells content type: review | 17 april 2014 the role of prothrombin complex concentrates in reversal of target specific anticoagulants authors: katrina babilonia and toby trujillo content type: review | 4 october 2005 heparin-induced thrombocytopenia: an update authors: massimo franchini most accessed articles rss view all articles aims and scope thrombosis journal is an open-access journal that publishes original articles on aspects of clinical and basic research, new methodology, case reports and reviews in the areas of thrombosis. topics of particular interest include the diagnosis of arterial and venous thrombosis, new antithrombotic treatments, new developments in the understanding, diagnosis and treatments of atherosclerotic vessel disease, relations between haemostasis and vascular disease, hypertension, diabetes, immunology and obesity. latest tweets latest article series and supplements state of the art 2016: research and review from the 9th congress of the asian-pacific society on thrombosis and hemostasis ​​​​​​the 9th congress of the asian-pacific society on thrombosis and hemostasis was held from 6-9 october 2016 in taipei, taiwan. as the official journal of the apsth, thrombosis journal has published a supplement of state of the art review and research articles in conjunction with the congress. inflammation and its role in thrombosis in recent years it has become increasingly clear that the immune system and coagulation pathways interact and influence one another. inflammation-induced thrombosis is considered a feature of several autoimmune diseases and thus such findings have important consequences for the treatment and management of such diseases. asian-pacific society on thrombosis and hemostasis the asian-pacific society of thrombosis and hemostasis (apsth) is a non-profit organization that welcomes any medical or scientific professionals with an interest in the field of thrombosis and hemostasis, particularly those professionals from the asia pacific region. the main objectives of apsth are to foster and advance clinical and scientific knowledge in the field of thrombosis, hemostasis and vascular biology through promotion of scientific exchange via meetings, publications, and promotion of international cooperation in clinical studies, and standardization of nomenclature and practices in the asia-pacific region. editors' quotes "open access is a critical element in dissemination of knowledge and research data throughout the world. in the field of thrombosis and haemostasis many developments are relevant, not only for the developed world, but also for those in underdeveloped nations where access to journals may be limited. the strength of thrombosis journal is that is can be accessed by everyone, everywhere. i strongly encourage scientists to submit their valuable data (clinical and basic research) to thrombosis journal , where we provide a platform for the full range of thrombosis and haemostasis related topics (also including case reports and special issue contributions)." hugo ten cate, editor-in-chief, thrombosis journal "treatment and prophylaxis of thrombotic and bleeding disorders is of great importance to the worldwide population, and there is a great need to facilitate the research activities related to this field. the aim of thrombosis journal is to provide a platform on which these important studies are visible to all members of the scientific community and public." yukio ozaki, editor-in-chief, thrombosis journal advertisement submit a manuscript official journal of thrombosis journal is the official journal of the asian-pacific society on thrombosis and hemostasis. members of apsth are entitled to a 15% discount on the article processing charge. editorial board sign up for article alerts and news from this journal follow follow us on twitter 2016 journal metrics speed 21 days from submission to first decision 11 days from acceptance to publication citation impact 1.395 - source normalized impact per paper (snip) 1.531 - scimago journal rank (sjr) 4.21 - citescore usage 214,746 downloads 1185.5 usage factor social media impact 27 mentions more about our metrics advertisement thrombosis journal